Literature DB >> 19545516

Minireview: clinical cryptosporidiosis.

Rachel M Chalmers1, Angharad P Davies.   

Abstract

Cryptosporidium has emerged as an important cause of diarrhoeal illness worldwide, especially amongst young children and patients with immune deficiencies. Usually presenting as a gastro-enteritis-like syndrome, disease ranges in seriousness from mild to severe and signs and symptoms depend on the site of infection, nutritional and immune status of the host, and parasite-related factors. Sources and routes of transmission are multiple, involving both zoonotic and anthroponotic spread, and facilitated by the resistance of the parasite to many commonly used disinfectants. Prevention and control measures are important for the protection of vulnerable groups since treatment options are limited. This review covers the life cycle, pathogenesis, clinical presentations, diagnosis, prevention and management of cryptosporidiosis in humans. Crown Copyright 2009. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19545516     DOI: 10.1016/j.exppara.2009.02.003

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  91 in total

Review 1.  Interaction forces drive the environmental transmission of pathogenic protozoa.

Authors:  Aurélien Dumètre; Dominique Aubert; Pierre-Henri Puech; Jeanne Hohweyer; Nadine Azas; Isabelle Villena
Journal:  Appl Environ Microbiol       Date:  2011-12-09       Impact factor: 4.792

2.  Development of an immunomagnetic bead separation-coupled quantitative PCR method for rapid and sensitive detection of Cryptosporidium parvum oocysts in calf feces.

Authors:  Shanshan Gao; Min Zhang; Said Amer; Jing Luo; Chengmin Wang; Shaoqiang Wu; Baohua Zhao; Hongxuan He
Journal:  Parasitol Res       Date:  2014-04-01       Impact factor: 2.289

3.  Anticryptosporidial effect of pomegranate peels water extract in experimentally infected mice with special reference to some biochemical parameters and antioxidant activity.

Authors:  D Aboelsoued; F A M Abo-Aziza; M H Mahmoud; K N Abdel Megeed; N M T Abu El Ezz; F M Abu-Salem
Journal:  J Parasit Dis       Date:  2019-01-14

4.  Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis.

Authors:  Suresh Kumar Gorla; Nina N McNair; Guangyi Yang; Song Gao; Ming Hu; Venkatakrishna R Jala; Bodduluri Haribabu; Boris Striepen; Gregory D Cuny; Jan R Mead; Lizbeth Hedstrom
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

5.  Correlation between diarrhea severity and oocyst count via quantitative PCR or fluorescence microscopy in experimental cryptosporidiosis in calves.

Authors:  Darwin J Operario; Lauren S Bristol; Janice Liotta; Daryl V Nydam; Eric R Houpt
Journal:  Am J Trop Med Hyg       Date:  2014-11-04       Impact factor: 2.345

6.  Multilocus genetic analysis of Cryptosporidium parvum from Egypt.

Authors:  Said Amer; Masoud Fayed; Hajime Honma; Yasuhiro Fukuda; Chica Tada; Yutaka Nakai
Journal:  Parasitol Res       Date:  2010-07-13       Impact factor: 2.289

7.  First report of Cryptosporidium species in farmed and wild buffalo from the Northern Territory, Australia.

Authors:  Alireza Zahedi; Jordan Phasey; Tony Boland; Una Ryan
Journal:  Parasitol Res       Date:  2016-01-13       Impact factor: 2.289

Review 8.  Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections.

Authors:  Jaco J Verweij; C Rune Stensvold
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

9.  Assessment of microscopic and molecular tools for the diagnosis and follow-up of cryptosporidiosis in patients at risk.

Authors:  Y Le Govic; K Guyot; G Certad; A Deschildre; R Novo; C Mary; B Sendid; E Viscogliosi; L Favennec; E Dei-Cas; E Fréalle; E Dutoit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-26       Impact factor: 3.267

10.  Cryptosporidiosis among children in an endemic semiurban community in southern India: does a protected drinking water source decrease infection?

Authors:  Rajiv Sarkar; Sitara S R Ajjampur; Ashok D Prabakaran; Jayanthy C Geetha; Thuppal V Sowmyanarayanan; Anne Kane; Joanne Duara; Jayaprakash Muliyil; Vinohar Balraj; Elena N Naumova; Honorine Ward; Gagandeep Kang
Journal:  Clin Infect Dis       Date:  2013-05-24       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.